Viewing nowCombinationLozaplem Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 201310333 · Approved 2013.11.27 · Insurance code 622801660
Treatment of hypertension not controlled with monotherapy
This medication is used additionally in hypertensive patients whose blood pressure is not sufficiently controlled with monotherapy, helping to effectively lower and control blood pressure.
○ Adults The usual dose of this drug is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg daily are not recommended. The maximum antihypertensive effect generally occurs around 3 weeks after starting treatment. This drug may be administered with other antihypertensive agents and may be taken regardless of meals. To minimize adverse reactions, start this drug when the expected effect is not achieved with monotherapy. 1. Substitution therapy: A combination regimen of individually titrated losartan potassium and hydrochlorothiazide may be replaced with this drug. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who develop hypokalemia despite blood pressure control at this dose: Treatment may be started with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which can reduce the hydrochlorothiazide dose without reducing the overall antihypertensive effect. Subsequently, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment The usual dose should be administered when creatinine clearance is 30 mL/min or more. Use of loop diuretics rather than thiazide drugs is preferable in patients with more severe renal impairment; therefore, use in these patients is not recommended. ○ Patients with hepatic impairment Because the initial losartan potassium dose of 25 mg required for patients with hepatic impairment cannot be administered using this drug, use in these patients is not recommended.
Children (under 18 years): Do not administer to children or adolescents.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy; it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any ingredients in this medication, certain kidney diseases, liver disorders, electrolyte imbalances, or anuria should not take this medication. Patients with low blood pressure, impaired kidney function, liver disorders, diabetes, and the elderly should use this medication cautiously and under the guidance of a physician. This medication lowers blood pressure, so dizziness or drowsiness may occur early in treatment, necessitating caution during driving or operating machinery. Blood electrolyte levels and kidney function should be monitored regularly during treatment to confirm there are no abnormalities. It is advisable not to use potassium supplements or potassium-containing medications during treatment, and to consult a doctor when combining with other antihypertensive medications or diuretics. Hydrochlorothiazide may cause heightened sensitivity to sunlight, increasing the risk of skin cancer; thus, sun exposure should be limited and skin condition should be checked periodically. Pregnant or breastfeeding women are advised not to use this medication; if breastfeeding, they should either discontinue nursing or consult a physician. Safety has not been established for use in children and adolescents, hence it should not be administered to them. Overdose may lead to symptoms such as hypotension, dehydration, or electrolyte imbalance, so prescribed dosages should be strictly followed, and any adverse effects should prompt immediate contact with a medical institution.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that excludes light, at room temperature between 1 degree and 30 degrees Celsius. Proper storage allows the medication to maintain its efficacy for a longer period.
Yellow oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.